Prostate Cancer Foundation

donate ribbon

Donate Now    FAQs   Contact Us   Español   twitter   facebook

Navigation

Prostate Cancer Research

Open RFA's

As new requests are made, this page will be updated with the relevant information. To stay up to date on awards as they become available, you can sign up for our awards notification list here.


Request for Applications: 2014 PCF Global Treatment Sciences (GTSN) Challenge Award For Lethal Prostate Cancer

The Prostate Cancer Foundation (PCF) is pleased to announce a Request for Applications for lethal prostate cancer. Approximately 5-10 GTSN Challenge Awards will be funded depending on level of innovation in applications received. High risk, first-in-field and currently unfunded projects are most desired.

PCF Challenge Awards support large-scale team science research projects concerning lethal prostate cancer over the duration of 2-3 years, provide up to a total of $1,000,000 per team and cover direct research costs only.

This award will support the correlative research around either clinical trials of novel agents or strategies of standard of care. One emphasis is on developing or validating biomarkers that guide therapy in patients or further our understanding of the mechanism by which therapies work. While the focus is on research in humans, the actual trials or treatments themselves will not be supported. Human samples are highly preferred, although at times, model systems might be required to complement the understanding of an important mechanism.

Please refer to the RFA for details on eligibility requirements and application submission guidelines.

The online application submission form will go live at www.pcfscience.org after July 22, 2014.

Deadline: September 22, 2014

Submit online application at www.pcfscience.org

Complete RFA (PDF)


Request for Applications: 2014 Clinical Scholar in Prostate Cancer

The Prostate Cancer Foundation of Norway is actively requesting applications for 2014 Clinical Scholar in Prostate Cancer.

The Observership will offer an opportunity to study clinical aspects of Prostate Cancer treatment at Johns Hopkins Medical Institution for up to 3 months.

PCFN will support travel to Baltimore and room and board expenses.

Applicants are required to have an MD degree and a documented clinical focus on Prostate Cancer.

Applicants should submit an CV and statement of work of no more than one page outlining their interest in prostate cancer and personal goals of their study.

Please send all applications to eschaeffer@jhmi.edu.


CLOSED: Request for Applications: 2014 Movember-PCF Global Treatment Sciences Network Challenge Award

(United States Applicants Only)

Due to a requirement by Movember, applications will be accepted from U.S. institutions only. To those of you outside the U.S., we look forward to receiving applications from you for future RFAs from other funding sources. Movember funds prostate cancer research regionally nearly everywhere on earth. We encourage those outside the U.S. to seek these opportunities.

The Prostate Cancer Foundation (PCF) is pleased to announce the 2014 Movember-PCF Global Treatment Sciences (GTSN) Challenge Awards. Approximately 8-12 GTSN Challenge Awards will be funded depending on level of innovation in applications received. High risk, currently unfunded projects are most desired.

These 2-year awards will provide a total of $1 million per team and focus on funding Treatment Sciences: Investigations of new ideas in man or laboratory support of a high impact clinical investigation.

Challenge Awards support large-scale research projects. Proposals must be from teams of at least 3 highly experienced investigators capable of providing unique scientific expertise to the solution of a significant problem in prostate cancer research. A team may be assembled from one or several institutions and must embed at least one young investigator as an integral contributor to the team.

Please refer to the RFA for details on eligibility requirements and application submission guidelines.

Deadline: The deadline for submission has passed.

Submit online application at www.pcfscience.org

Complete RFA (PDF)


CLOSED: Request for Applications: Prostate Cancer Foundation 2014 Young Investigator Awards

PCF Young Investigator awards will be three (3) years in duration and will provide $75,000 per year. The award funds may be used flexibly to advance the career and research efforts of the awardee. This, for example, includes funding “protected time” or direct costs for experiments.

Documentation of an equal in-kind level of support will be requested in the form of dedicated space, equipment, institutional overhead, core institutional resources, etc. The documentation required is a letter from the Cancer Center Director or Departmental Chairperson which confirms institutional commitment to the career development of the PCF Young Investigator while under the direct supervision of a Mentor. Mentorship is required for every PCF Young Investigator applicant and grantee. Young Investigator awardees and their Mentors will be required to attend the annual PCF Scientific Retreat in October 2014.

Deadline: The deadline for submission has passed.


CLOSED: Request for Applications: Movember – PCF Challenge Award 2013

The Prostate Cancer Foundation (PCF) is pleased to announce a new 2013 Movember-PCF Challenge Award Request for Applications related to immunotherapy for the treatment of advanced, metastatic prostate cancer.

This Award will support one large-scale research project concerning metastatic prostate cancer over a duration of two years, providing up to a total of $1 million for one team. The Award will cover direct research costs only.

The 2013 Movember-PCF Challenge Award will focus on funding translational and clinical science to advance immunotherapy. Areas of particular interest to PCF include but are not limited to: (1) adoptive engineered T cell therapy; (2) Checkpoint inhibition therapy; (3) Development of rational combination/sensitization immunotherapy regimens; (4) Characterization of biomarker(s) that predict response or innate resistance to immunotherapy; (5) Other novel first-in-field immunotherapy strategies with near term translational potential.

Proposals must be from teams of at least 3 highly experienced investigators capable of providing unique scientific expertise to the solution of a significant problem in prostate cancer research. The team may be assembled from one institution or several institutions from across the globe, and must embed a young investigator as an integral contributor to the team.

Deadline: The deadline for submission has passed.


CLOSED: Request for Applications: Prostate Cancer Foundation 2013 Challenge Award

The 2013 PCF Challenge Awards will provide a two-year award per team of up to $1,000,000 for direct costs only.

These awards support large-scale research projects from teams of at least 3 highly experienced investigators capable of providing unique scientific expertise to the solution of a significant problem in prostate cancer research. The team may be assembled from one institution or several institutions from across the globe, and must embed a young investigator as an integral contributor to the team.

The 2013 PCF Challenge Awards focus on funding Treatment Sciences: Investigations of new ideas in man or laboratory support of a high-impact clinical investigation with a high probability of near-term patient benefit.

One of our Challenge awards will be funded in conjunction with Dana-Farber/Harvard Cancer Center (DF/HCC) and designated as an A. David Mazzone-PCF Challenge Award (see additional A. David Mazzone funding opportunities below).

Deadline: The deadline for submission has passed.

Submit online application at www.pcfscience.org.

Complete RFA (PDF)


CLOSED: Request for Applications: A. David Mazzone Awards Program Funding Opportunities 2013

The A. David Mazzone Awards Program (a non-Federal funding opportunity) is now accepting applications for its third year of funding. Two of these award categories will be funded by DF/HCC in the amount of $100,000 to $500,000 per project.

Program Summary and Full RFAs Text: A David Mazzone Awards Program

Letter of Intent and Application Submission Website: https://mazzone.dfci.harvard.edu/

Please direct questions to: jhincapie@partners.org


CLOSED: Request for Applications: Prostate Cancer Foundation 2013 Young Investigator Awards

PCF Young Investigator awards will be three (3) years in duration and will provide $75,000 per year. The award funds may be used flexibly to advance the career and research efforts of the awardee. This, for example, includes funding “protected time” or direct costs for experiments. Documentation of an equal in-kind level of support will be requested in the form of dedicated space, equipment, institutional overhead, core institutional resources, etc. The documentation required is a letter from the Cancer Center Director or Departmental Chairperson which confirms institutional commitment to the career development of the PCF Young Investigator while under the direct supervision of a Mentor. Mentorship is required for every PCF Young Investigator applicant and grantee. Young Investigator awardees and their Mentors will be required to attend the annual PCF Scientific Retreat in October 2013.

Deadline: The deadline for submission has passed.

Complete RFA (PDF)


CLOSED: Request for Applications: Melanoma Research Alliance (MRA)–Prostate Cancer Foundation (PCF) Team Science Partnership Award

Applications are solicited by the Melanoma Research Alliance (MRA) and the Prostate Cancer Foundation (PCF) for one jointly sponsored Team Science Award that will simultaneously advance clinical science in both diseases. A total award amount of up to $1.5 million over 2-3 years is offered to support innovative, meritorious and translational work with the potential for high clinical impact in prostate cancer and melanoma. The following are examples of investigative areas relevant to both kinds of cancer, for which applications will be considered: 1) nuclear imaging technologies and/or applications as early predictors of treatment outcomes, including novel tracers to distinguish immune from tumor cells in the context of immunotherapy; 2) therapeutic interventions targeting tumor cell metabolism and protein translation; and 3) development of effective combinatorial therapies in the adjuvant or advanced disease setting, based on immune-modulating drugs paired with other agents.

Deadline: The deadline for submission has passed.

Complete RFA (PDF)


CLOSED: Request for Applications: Prostate Cancer Foundation announces the PCF-Honorable A. David Mazzone Special Challenge Award Research Program 2012.

These two-year awards will provide a total of $1 million per team. Challenge Awards support large-scale research projects. Proposals must be from teams of at least 3 highly experienced investigators capable of providing unique scientific expertise to the solution of a significant problem in prostate cancer research. A team may be assembled from one institution, or several institutions, from across the globe. These awards focus on funding Treatment Sciences: Investigations of new ideas in man or laboratory support of a high impact clinical investigation.

Deadline: The deadline for submission has passed.

Complete RFA (PDF)


CLOSED: Request for Applications: A. David Mazzone Awards Program Funding Opportunities 2012

The A. David Mazzone Awards Program (a non-Federal funding opportunity) is now accepting applications for its second year of funding. Two of these award categories will be funded by DF/HCC in the amount of $100,000 to $500,000 per project. The third award category, provided by the Dana-Farber/Harvard Cancer Center (DF/HCC) in conjunction with the Prostate Cancer Foundation (PCF), will fund $1million per project.

DF/HCC Funding Support Center


CLOSED: Request for Applications: The Prostate Cancer Foundation has been contracted by the Coalition to Cure Prostate Cancer to administer the Coalition to Cure Prostate Cancer (CCPC) 2012 Young Investigator Award program. The CCPC will fund four (4) Young Investigators in Canada in 2012.

Consistent with CCPC’s goal to end death and suffering from prostate cancer, these awards are focused on developing a gifted cohort of investigators to undertake the next generation of prostate cancer research. The awards will be three years in duration and will provide $75,000 per year in financial support to advance the career and research efforts of the awardees. Mentorship is required for every CCPC Young Investigator Award applicant and grantee. We therefore beseech established investigators to identify, mentor, and encourage qualified candidates to apply for this award.

The award description and eligibility requirements are available at www.coalitiontocureprostatecancer.org.

Deadline: The deadline for submission has passed.

Complete RFA (PDF)


CLOSED: Request for Applications: SU2C-PCF Prostate Dream Team Translational Cancer Research Grant

Stand Up To Cancer and the Prostate Cancer Foundation, along with the American Association for Cancer Research, call upon the cancer research community to submit letters of intent for a new Dream Team dedicated to prostate cancer research. We invite submission of ideas for translational cancer research projects that would address therapeutic interventions for advanced prostate cancer with special emphasis on metastatic disease, and deliver near-term patient benefit through investigation by a multidisciplinary, multi-institutional, synergistic Dream Team of expert investigators.

Deadline: The deadline for submission has passed.

AACR RFA

 


CLOSED: Request for Applications: Prostate Cancer Foundation Young Investigator Awards 2011

The Prostate Cancer Foundation champions human capital investment to fast-forward solutions to prostate cancer. We are pleased to announce a new round of funding for Prostate Cancer Researchers. Consistent with our goal to end death and suffering from prostate cancer, we would like to focus efforts on developing another gifted cohort of human capital in prostate cancer research. Highly innovative basic science programs will be carefully considered, but priority will be given to "bench to bedside" translational research proposals with the potential to deliver near term benefit to patients.

Deadline: The deadline for submission has passed.

Complete RFA (PDF)


CLOSED: Request for Applications: Prostate Cancer Foundation-Honorable A. David Mazzone Special Challenge Award Research Program 2011

The Prostate Cancer Foundation (PCF) is pleased to announce a new Challenge Award funding opportunity entitled the PCF-Honorable A. David Mazzone Special Challenge Award Research Program.

These two-year awards will provide a total of $1 million per team. Challenge Awards support large-scale research projects. Proposals must be from teams of at least 3 highly experienced investigators capable of providing unique scientific expertise to the solution of a significant problem in prostate cancer research. A team may be assembled from one institution, or several institutions, from across the globe.

This round of awards will focus on funding Treatment Science: studies of new ideas in man or laboratory support of a high impact clinical investigation.

Note: The funding agency for the Program is a grant from the U.S. District Court for the District of Massachusetts of a pool of unclaimed funds from the 2004 class action suit settlement by TAP Pharmaceuticals. The class action suit was related to marketing and sales practices for the prostate cancer drug Lupron. The program is administered jointly through DF/HCC and the Prostate Cancer Foundation.

Deadline: The deadline for submission has passed.

Complete RFA (PDF)

 


CLOSED: Request for Applications: Treatment Sciences Creativity Awards 2011

The Prostate Cancer Foundation (PCF) is now accepting applications for the PCF 2011 Creativity Awards. This funding mechanism will provide two years of support (up to $150,000 per year for direct costs only) for highly innovative prostate cancer research proposals that are not fundable by other existing mechanisms.

This round of awards will focus on funding Treatment Science: studies of new ideas in man or laboratory support of a high impact clinical investigation.

Deadline: The deadline for submission has passed.

Complete RFA (PDF)

Please review this list of FAQs before contacting PCF.

Print | Bookmark and Share

2000 Programs Worldwide

Progress Reports

prostate cancer guides and books

prostate cancer clinical trials

patient support

athletes for a cure